What Justices Are Focusing On In 'Skinny Label' Patent Case
On April 29, the U.S. Supreme Court heard oral argument in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., a closely watched case involving so-called skinny labels under the Hatch-Waxman Act...To view the full article, register now.
Already a subscriber? Click here to view full article